Catalyst Brief

← Calendar

ReadoutIn window

Sanofi — Yellow fever vaccine (live)

Phase 3 primary completion: A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population.

Date
Nov 2026
Type
Readout
Indication
Yellow Fever Immunization

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.

More from Sanofi

  1. May2027
  2. Apr2027
    Readoutin 135d
    Sanofi — Isatuximab SAR650984
    Phase 3 primary completion: A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant.